Valentina Tateo, Joep de Jong, Antonio Cigliola, Brigida Anna Maiorano, Chiara Mercinelli, Emanuele Crupi, Daniele Raggi, Patrizia Giannatempo, Maurizio Colecchia, Marco Moschini, Elai Davicioni, Alberto Briganti, Francesco Montorsi, Daniele Santini, Andrea Necchi. "The estrogen response pathway as a putative predictive biomarker of neoadjuvant pembrolizumab benefit in patients with muscle-invasive bladder carcinoma (MIBC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.843